A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition

被引:468
作者
Malhotra, AK
Kestler, LJ
Mazzanti, C
Bates, JA
Goldberg, T
Goldman, D
机构
[1] Hillside Hosp, Unit Mol Psychiat, Glen Oaks, NY 11004 USA
[2] NIAAA, Neurogenet Lab, Rockville, MD 20852 USA
关键词
D O I
10.1176/appi.ajp.159.4.652
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: In the prefrontal cortex, the enzyme catechol O-methyltransferase (COMT) is critical in the metabolic degradation of dopamine, a neurotransmitter hypothesized to influence human cognitive function. The COMT gene contains a functional polymorphism, Val158Met, that exerts a fourfold effect on enzyme activity. The current study investigated whether prefrontal cognition varies with COMT genotype. Method: Val158Met was genotyped in 73 healthy volunteers. A task of prefrontal cognition, the Wisconsin Card Sorting Test, was also administered. Results: Subjects with only the low-activity met allele made Significantly fewer perseverative errors on the Wisconsin Card Sorting Test than did subjects with the val allele. Conclusions: These data are consistent with those of previous studies, suggesting that a functional genetic polymorphism may influence prefrontal cognition.
引用
收藏
页码:652 / 654
页数:3
相关论文
共 12 条
  • [1] Allison DB, 1997, AM J HUM GENET, V60, P676
  • [2] Cognition and control in schizophrenia: A computational model of dopamine and prefrontal function
    Braver, TS
    Barch, DM
    Cohen, JD
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 46 (03) : 312 - 328
  • [3] Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
    Egan, MF
    Goldberg, TE
    Kolachana, BS
    Callicott, JH
    Mazzanti, CM
    Straub, RE
    Goldman, D
    Weinberger, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) : 6917 - 6922
  • [4] Cognitive improvement during tolcapone treatment in Parkinson's disease
    Gasparini, M
    Fabrizio, E
    Bonifati, V
    Meco, G
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (8-9) : 887 - 894
  • [5] Heaton R.K., 1981, MANUAL WISCONSIN CAR
  • [6] Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat
    Jentsch, JD
    Tran, A
    Le, D
    Youngren, KD
    Roth, RH
    [J]. NEUROPSYCHOPHARMACOLOGY, 1997, 17 (02) : 92 - 99
  • [7] 3-METHOXYTYRAMINE IS THE MAJOR METABOLITE OF RELEASED DOPAMINE IN THE RAT FRONTAL-CORTEX - REASSESSMENT OF THE EFFECTS OF ANTIPSYCHOTICS ON THE DYNAMICS OF DOPAMINE RELEASE AND METABOLISM IN THE FRONTAL-CORTEX, NUCLEUS-ACCUMBENS, AND STRIATUM BY A SIMPLE 2-POOL MODEL
    KAROUM, F
    CHRAPUSTA, SJ
    EGAN, MF
    [J]. JOURNAL OF NEUROCHEMISTRY, 1994, 63 (03) : 972 - 979
  • [8] KNEAVEL M, 2000, SOC NEUROSCI, V26, P1535
  • [9] Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
    Lachman, HM
    Papolos, DF
    Saito, T
    Yu, YM
    Szumlanski, CL
    Weinshilboum, RM
    [J]. PHARMACOGENETICS, 1996, 6 (03): : 243 - 250
  • [10] Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11
    Li, T
    Ball, D
    Zhao, J
    Murray, RM
    Liu, X
    Sham, PC
    Collier, DA
    [J]. MOLECULAR PSYCHIATRY, 2000, 5 (01) : 77 - 84